ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (Nasdaq: CSII), a medical device company developing and commercializing innovative, interventional treatment systems for vascular disease, will present at the Eighth Annual JMP Securities Research Conference at The Ritz-Carlton, San Francisco. President and Chief Executive Officer David L. Martin, and Chief Financial Officer Laurence L. Betterley, will provide an overview of the company.
